PTC(PTC)
Search documents
PTC(PTC) - 2024 Q4 - Earnings Call Presentation
2024-11-06 23:55
Financial Performance - Q4'24 ARR as reported was $2,255 million, a 14% year-over-year increase[8] - Constant currency ARR at FY'24 Plan FX rates was $2,207 million, a 12% year-over-year increase[8] - Q4'24 operating cash flow was $98 million, a 97% year-over-year increase[9] - Q4'24 free cash flow was $94 million, a 113% year-over-year increase[9] - FY'24 operating cash flow was $750 million, a 23% year-over-year increase[9] - FY'24 free cash flow was $736 million, a 25% year-over-year increase[9] Guidance - FY'25 constant currency ARR is projected to grow by 9% to 10%, reaching $2,469 million[19,20] - FY'25 free cash flow is guided to be between $835 million and $850 million, a 14% to 16% increase[19] - Q1'25 constant currency ARR is expected to grow by approximately 10.5%[19] - FY'25 revenue is expected to be between $2,505 million and $2,605 million, a 9% to 13% increase[19] Capital Allocation - The company intends to repurchase approximately $300 million of common stock in FY'25[17,29] - The company plans to retire $500 million in senior notes due in February 2025 using cash on hand and drawing on the revolving credit facility[16,29]
PTC Inc. (PTC) Q4 Earnings and Revenues Beat Estimates
ZACKS· 2024-11-06 23:21
PTC Inc. (PTC) came out with quarterly earnings of $1.54 per share, beating the Zacks Consensus Estimate of $1.43 per share. This compares to earnings of $1.20 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 7.69%. A quarter ago, it was expected that this product development software maker would post earnings of $0.98 per share when it actually produced earnings of $0.98, delivering no surprise.Over the last four quarters, the ...
PTC ANNOUNCES $2 BILLION SHARE REPURCHASE AUTHORIZATION
Prnewswire· 2024-11-06 21:01
BOSTON, Nov. 6, 2024 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced that its Board of Directors has authorized the repurchase of up to $2 billion worth of PTC common stock through September 30, 2027."This repurchase authorization demonstrates the Board's confidence in PTC's ability to drive customer value while enhancing shareholder returns, and supports PTC's capital allocation strategy," said Janice Chaffin, Chair of the Board."PTC intends to repurchase approximately $300 million of our common stock in ...
PTC ANNOUNCES FOURTH FISCAL QUARTER AND FULL FISCAL YEAR 2024 RESULTS
Prnewswire· 2024-11-06 21:01
Solid ARR and Cash Flow in Fourth Fiscal Quarter and Full Fiscal YearBOSTON, Nov. 6, 2024 /PRNewswire/ -- PTC (NASDAQ: PTC) today reported financial results for its fourth fiscal quarter and full fiscal year ended September 30, 2024."In fiscal year 2024, we again delivered solid ARR and cash flow, with year-over-year ARR growth in the low double-digits and cash flow growth above 20%. We have a differentiated strategy that leverages our unique portfolio to help product companies accelerate their time to mark ...
PTC(PTC) - 2024 Q4 - Annual Results
2024-11-06 21:00
EX 99.1 PTC ANNOUNCES FOURTH FISCAL QUARTER AND FULL FISCAL YEAR 2024 RESULTS Solid ARR and Cash Flow in Fourth Fiscal Quarter and Full Fiscal Year BOSTON, MA, November 6, 2024 - PTC (NASDAQ: PTC) today reported financial results for its fourth fiscal quarter and full fiscal year ended September 30, 2024. "In fiscal year 2024, we again delivered solid ARR and cash flow, with year-over-year ARR growth in the low double-digits and cash flow growth above 20%. We have a differentiated strategy that leverages ou ...
PTC Inc. (PTC) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates
ZACKS· 2024-11-01 14:20
Wall Street analysts forecast that PTC Inc. (PTC) will report quarterly earnings of $1.43 per share in its upcoming release, pointing to a year-over-year increase of 19.2%. It is anticipated that revenues will amount to $620.49 million, exhibiting an increase of 13.5% compared to the year-ago quarter.The consensus EPS estimate for the quarter has undergone a downward revision of 1.1% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed ...
PTC Inc. (PTC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
ZACKS· 2024-10-30 15:07
Wall Street expects a year-over-year increase in earnings on higher revenues when PTC Inc. (PTC) reports results for the quarter ended September 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates. The earnings report, which is expected to be released on November 6, 2024, might help the stock move higher if these key numbers are better than ex ...
Vishay Intertechnology High Energy Inrush Current Limiting PTC Thermistors Increase Performance in Active Charge and Discharge Circuits
GlobeNewswire News Room· 2024-10-30 15:00
MALVERN, Pa., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Vishay Intertechnology, Inc. (NYSE: VSH) today introduced a new series of inrush current limiting positive temperature coefficient (PTC) thermistors. Designed to increase performance in active charge and discharge circuits for automotive and industrial applications, Vishay BCcomponents PTCEL High Energy series devices combine maximum energy handling to 340 J — five times higher than competing devices at high ambient temperatures — with a wide range of resistan ...
PTC Therapeutics Announces FDA Acceptance of Translarna™ NDA Resubmission
Prnewswire· 2024-10-30 11:00
WARREN, N.J., Oct. 30, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today the U.S. Food and Drug Administration (FDA) has accepted for review the resubmission of the New Drug Application (NDA) for Translarna™ (ataluren) for the treatment of nonsense mutation Duchenne muscular dystrophy (nmDMD). "The NDA acceptance for review is a significant milestone that brings us one step closer to providing this important treatment to boys and young men living with nonsense mutation Duchenne musc ...
PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2024 Financial Results
Prnewswire· 2024-10-24 11:00
WARREN, N.J., Oct. 24, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will host a webcast conference call to report its third quarter 2024 financial results and provide an update on the company's business and outlook on Thursday, Nov. 7, at 4:30 p.m. EST.To access the call by phone, please click here to register and you will be provided with dial-in details. To avoid delays, we recommend participants dial in to the conference call 15 minutes prior to the start of ...